tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Financial Statements

Compare
22 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently $8.67B. The company's EPS TTM is $0.051; its P/E ratio is 12.50; and it has a dividend yield of 5.99%. CSPC Pharmaceutical Group is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 30.87B¥ 34.60B¥ 31.59B¥ 33.59B¥ 28.03B
Gross Profit¥ 21.60B¥ 24.40B¥ 22.73B¥ 25.47B¥ 21.00B
Operating Income¥ 5.71B¥ 7.68B¥ 6.93B¥ 7.53B¥ 6.11B
EBITDA¥ 6.69B¥ 8.53B¥ 7.60B¥ 9.28B¥ 8.09B
Net Income¥ 4.61B¥ 5.87B¥ 5.35B¥ 5.61B¥ 5.16B
Balance Sheet
Cash & Short-Term Investments¥ 8.60B¥ 13.09B¥ 13.68B¥ 13.12B¥ 10.47B
Total Assets¥ 47.23B¥ 46.28B¥ 41.18B¥ 42.50B¥ 35.65B
Total Debt¥ 507.33M¥ 706.90M¥ 574.32M¥ 115.04M¥ 375.51M
Net Debt¥ -6.27B¥ -11.31B¥ -9.58B¥ -11.24B¥ -8.27B
Total Liabilities¥ 11.20B¥ 11.26B¥ 9.72B¥ 9.37B¥ 7.96B
Stockholders' Equity¥ 32.26B¥ 30.07B¥ 29.77B¥ 31.79B¥ 26.48B
Cash Flow
Free Cash Flow¥ 0.00¥ 2.29B¥ 5.32B¥ 3.74B¥ 5.91B
Operating Cash Flow¥ 0.00¥ 4.18B¥ 8.10B¥ 5.86B¥ 7.67B
Investing Cash Flow¥ 0.00¥ 607.27M¥ -7.19B¥ -1.06B¥ -2.60B
Financing Cash Flow¥ 0.00¥ -2.30B¥ -1.95B¥ -2.65B¥ -1.65B
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History

CSPC Pharmaceutical Group Debt to Assets

CSPC Pharmaceutical Group Cash Flow

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis